Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX464 in Untreated HIV Infection
NCT02452242Phase 2Completed
- Sponsor
- Abivax
- Start
- Jan 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of obefazimod in human immunodeficiency virus infection (HIV), sponsored by Abivax. Started Jan 2015; status: completed.
02
Drugs
obefazimod
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02452242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452242.